Anastasia Semykina is a Professor of Economics and Deputy Dean (Research and Innovation) at RMIT University's School of Economics, Finance & Marketing. She holds a PhD from Michigan State University (2006) and previously served as Charles and Joan Haworth Professor of Economics at Florida State University. Her expertise spans theoretical and applied econometrics, with a focus on panel data models, missing data estimation, and their application in labor economics, education economics, transition economies, and economic psychology. She teaches advanced econometrics and microeconomics courses at both undergraduate and graduate levels. Research Interests: Theoretical and Applied Econometrics Labor Economics Economics of Education Transition Economies Economics and Psychology Health Economics Her recent publications address topics such as panel data methodologies, healthcare cost-effectiveness analysis, and educational policy evaluation. She is actively involved in supervising PhD and Master's research students in econometrics and applied economics.
Professor Jennifer Whitty is an applied health economist at the University of East Anglia , affiliated with the Norwich Medical School and the Centre of Research Excellence in Telehealth . Her research bridges health economics, patient preferences, and health policy, with a focus on quality of life valuation and economic evaluation. Education: Doctor of Philosophy (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992) Her work emphasizes person-centered methodologies , particularly discrete choice experiments, to evaluate patient and public preferences for healthcare delivery and outcomes. Key research areas include: Treatment burden and quality of life in chronic diseases like cystic fibrosis Economic evaluation of pharmaceuticals and health technologies Asset-based approaches to community health Priority-setting frameworks in health policy Prof. Whitty has secured over AU$27 million in research funding from organizations including the NHMRC and National Institute for Health and Care Research , and serves on editorial boards for Medical Decision Making and Applied Health Economics and Health Policy .
Professor Shaun Larkin is a part-time academic at the School of Public Health , University of Sydney, specializing in Health Policy and Financing . He is affiliated with the Leeder Centre for Health Policy, Economics and Data and a member of the Charles Perkins Centre . With a career spanning executive roles at HCF and non-executive directorships in health startups, his work bridges academia and industry. Education : Harvard Business School alumnus with a HlthScD, MBA, MHSc, and BHA. His research focuses on health economics , health policy , and health services management , emphasizing: Translational research in healthcare financing Trends in private-public healthcare partnerships Price transparency in private health insurance Leadership in health systems Chronic disease management Quality use of medicines His publications reveal a trajectory from foundational work in: Psychiatric services data standardization (2000) Heart disease and diabetes management (2013-2015) Telehealth interventions (2017-2018) Private sector policy frameworks (2019-2020) Saudi Arabian health reforms (2022-present) Private equity in healthcare (2025) As an advisor, he currently supervises research students on topics including: Quality use of medicines in Saudi Arabia Sustainable financial models for private hospitals Patient-reported outcome measures in Australia He also contributes to the Leeder Centre and engages with global health startups as an investor and advisor.
Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.
Professor Guy Wallis is a Professor and Director of Research at the School of Human Movement and Nutrition Sciences, Faculty of Health, Medicine and Behavioural Sciences at the University of Queensland. He is also an Affiliate of the Centre for Sensorimotor Performance. His work bridges visual neuroscience, computational modeling, and applied human factors research, with significant contributions to understanding visual recognition and visuomotor behavior. Education: Bachelor (Honours) of Engineering in Electrical and Electronic Engineering from Imperial College London PhD in Visual Neuroscience from University of Oxford, UK Prof. Wallis's research program combines computational modeling with behavioral studies, many conducted in computer-controlled virtual environments. His work spans visual neuroscience, object recognition, visuomotor control, and simulator-based training. He has made significant theoretical contributions to understanding how visual recognition is achieved in biological systems and how everyday visuomotor tasks are regulated, challenging existing paradigms and offering new insights. His recent publications reveal a strong focus on virtual reality applications, visual-motor integration challenges, and cross-species cognitive studies. There's a clear trend toward investigating how virtual environments can be optimized for training and assessment, with particular attention to visual perception limitations and how humans adapt to these environments across diverse contexts from surgical training to aviation. Scientific Awards and Recognitions: Elected Fellow of the Queensland Academy of Arts and Sciences (2022) ARC Medical Research Advisory Group (2022-2024) ARC College of Experts (2019-2021) CSIRO CSS Human Research Ethics Committee member (2020-2022) UQ Health and Behavioural Sciences Faculty, HDR Supervision Award (2018) ARC Future Fellowship (2011-2014) ARC QEII Fellowship (2003-2007) UQ Postdoctoral Fellowship (2001-2003) Prof. Wallis has successfully secured funding from major organizations including the Australian Research Council, the Human Frontier Science Program, and the Wellcome Trust. His industry partnerships span diverse sectors such as construction training, mining, healthcare, and aerospace. His research has led to the development of novel training programs for health professionals, impacted the design of man-machine interfaces for mining equipment, and informed the design parameters for pilot training systems. As Director of Research, he oversees the research direction of the School of Human Movement and Nutrition Sciences, fostering interdisciplinary collaborations and supporting early-career researchers through his leadership in the Centre for Sensorimotor Performance.
Janani Thillainadesan is an NHMRC Senior Research Fellow at the Sydney Medical School/Concord Clinical School and the Centre for Education and Research on Ageing, affiliated with the Faculty of Medicine and Health at the University of Sydney. She is also a member of the Charles Perkins Centre. Her research focuses on optimizing healthcare delivery for older adults, particularly in geriatric surgery, perioperative care, and dementia interventions. Key research areas include frailty assessment, deprescribing strategies, collaborative care models, and leveraging technology (e.g., mobile health) in geriatric medicine. She has contributed to multidisciplinary studies involving clinical datasets, quality indicators, and mixed-methods analyses of patient experiences and care expectations. Awards: 2023 RACP Vincent Fairfax Research Fellowship 2021 ANZSGM Career Investigator Prize 2021 UK Age Anaesthesia Association Best Oral Presentation Prize 2019 Evidence Based Perioperative Medicine Asia Congress Runner Up Prize Her work bridges clinical practice, education, and policy through grants like the 2024 electronic frailty index project. Media engagement includes a 2019 Studio 10 segment highlighting her contributions to aging-related healthcare innovations.
Associate Professor Ken Chung is affiliated with the University of Sydney's School of Project Management, serving as Associate Head of Education. He holds a PhD (University of Sydney) and dual undergraduate degrees (B.Sc (Hons I), B.Com). His research focuses on social network theory applied to stakeholder engagement in projects, healthcare coordination, and complex systems. Notable awards include the 2021 Faculty of Engineering Dean's Award for Excellence in Teaching and a PMI grant for infrastructure stakeholder engagement research. He has collaborated with organizations like NSW Department of Planning, Google, and Western Sydney Airport. Teaching includes courses like ENGG1850 and PMGT5871. Current projects explore stakeholder analysis, community engagement in infrastructure, and healthcare networks. His expertise spans 20+ years, with international partnerships at Webster Vienna and University of Southern Denmark. Professional activities include editorial roles, ARC grant reviewing, and industry advisory roles. Education highlights: PhD in Information Technologies (2009, Sydney), prior lectureship at University of Wollongong. Industry experience includes Telstra Messaging Group and DoubleClick Australia. Research integrates social physics principles, examining network structures' impact on project success, healthcare outcomes, and organizational behavior. Grants include ARC DP-funded health research and PMI-funded infrastructure studies. Key themes include network-based models for stakeholder engagement, project management innovation, and social capital utilization.
Dr. Jannah Baker is a Research Fellow at the Sydney School of Public Health, University of Sydney. She holds a PhD in Statistics specializing in Bayesian spatiotemporal modelling of chronic diseases, alongside dual postgraduate diplomas in Public Health and Statistics. Her clinical background includes five years as a practicing physician. Her research focuses on cancer prevention (breast, endometrial, melanoma), spatiotemporal disease modeling, health economics, and clinical trial design. She has led projects on sepsis detection systems, diabetes management, and surgical outcomes analysis. Notable contributions include a seminal systematic review on fertility-sparing endometrial cancer treatments referenced in international guidelines. Jannah has attracted $6M+ in collaborative funding and oversees grants such as the 2023 NHMRC-funded ROADMAP trial and a Department of Health-funded study on pediatric sepsis management. Her work spans 50+ peer-reviewed articles across journals like Journal of Medical Internet Research and PLOS One . Professional activities include clinical trials statistics, health economics analysis, and implementation science lectures. She has mentored multiple research teams and maintains an ORCID profile (0000-0002-2208-6584).
Hsei Di Law is a Research Fellow at the National Centre for Epidemiology and Population Health (NCEPH), part of the Australian National University (ANU). She is concurrently pursuing an MSc in Computational Data Analytics at the Georgia Institute of Technology . Her work focuses on data linkage, machine learning, and epidemiological study design using whole-of-population linked datasets. Research Affiliations National Centre for Epidemiology and Population Health (ANU) Centre of Epidemiology for Policy and Practice Linked Data for Better Health group Health Experience and Health Services Research collaborator Research Interests : Hsei Di Law's work centers on large-scale linked administrative datasets and longitudinal data analysis , with applications in environmental contamination (PFAS, asbestos), healthcare economics (out-of-pocket costs), and epidemiology of diseases. She specializes in integrating machine learning techniques with epidemiological study design to address policy-relevant questions. Publication Trends : Her recent publications (2025–2023) analyze healthcare affordability in Australia, PFAS environmental health impacts , and data linkage methodologies . Over 2022–2015, she studied cardiovascular risk under-treatment , COVID-19 healthcare outcomes , and immune system disorders using mouse models. Projects Led : She is involved in multiple projects, including the ACT Asbestos Health Study II , PFAS Health Study , and Whole-of-population linked data project . These projects examine the health effects of asbestos and PFAS contamination , healthcare utilization, and epidemiological modeling . Contact : Email: hsei-di.law@anu.edu.au Phone: +61 2 6125 0547 Location: Building 62A, Room 2.56, ANU
Associate Professor Ernest Ekpo is affiliated with the University of Sydney's Sydney School of Health Sciences, within the Discipline of Medical Imaging Sciences. He holds academic roles as a Scholarly Teaching Fellow and Co-Director of the Medical Image Optimisation and Perception Group (MIOPeG). He is also an Associate Editor of the Journal of Medical Imaging and Radiation Sciences and a member of the Sydney Southeast Asia Centre and Cancer Research Network. Education: Earned BSc (Hons) in Radiography/Sonography from the University of Calabar, Nigeria, and a PhD from the University of Sydney. His research focuses on breast density, cancer biomarkers, medical image perception, radiation dose optimization, and radiology education. He explores applications in low-resource settings and emerging technologies like AI for diagnostic accuracy. Research interests include breast cancer treatment outcomes, image-based phenotypes, and improving imaging pathways for acute abdominal pain. Key themes are Cancer and Medical Imaging, with an emphasis on Women's Health and Chronic Disease. His work combines clinical practice, public health strategies, and technological advancements to enhance diagnostic efficacy and reduce unnecessary procedures. Articles from 2021–2024 highlight his contributions in mammography optimization, radiographer training, and AI-driven diagnostic tools. Recent grants include a 2024 project on CT examination education and a 2023 initiative to streamline breast cancer screening pathways. His awards recognize peer review excellence, early-career teaching, and research leadership. He supervises multiple students investigating breast density biomarkers, imaging modalities for dense breasts, and radiation dose management. His educational efforts aim to improve radiographers' capabilities in identifying urgent findings across CT and X-ray modalities, leveraging blended learning approaches.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She is an NHMRC Leadership Fellow (2021–2025) and a Chief Investigator for the NHMRC Centre of Research Excellence in Pulmonary Fibrosis and the NHMRC Centre of Research Excellence in Treatable Traits. Her research focuses on supportive therapies for chronic respiratory diseases, particularly COPD and pulmonary fibrosis, with a strong emphasis on pulmonary rehabilitation, telerehabilitation, and ambulatory oxygen therapy. Her research interests include: Respiratory physiotherapy Pulmonary rehabilitation (home-based and low-cost models) Access to care for chronic lung disease Telerehabilitation and digital health Symptom management in interstitial lung disease Exercise training and physical activity promotion Her recent publications focus on symptom management, digital self-management tools, treatable traits models, and clinical trials in pulmonary fibrosis and COPD. The body of work reflects a strong trend toward patient-centered, accessible, and evidence-based interventions that improve quality of life and clinical outcomes in chronic respiratory conditions. Her major scientific awards include: Society Medal, Thoracic Society of Australia and New Zealand (2021) European Respiratory Society Gold Medal for Allied Health Professionals (2022) NHMRC Investigator Fellow (Leadership 1) (2021) Fellow, Thoracic Society of Australia and New Zealand (2019) American Thoracic Society Pulmonary Rehabilitation Assembly Award (2016) Anne Holland supervises PhD students and is actively involved in advising and grant leadership. She is the Primary Chief Investigator on major trials such as the PERFORM trial and the TAPPET trial, and she leads a multinational ambulatory oxygen trial for fibrotic lung disease. Her work is supported by NHMRC and international collaborations. She is also President of the Thoracic Society of Australia and New Zealand, reflecting her leadership in the field. Anne leads the Holland Respiratory Care Research Group at Monash, which focuses on innovative models of care delivery, validation of remote monitoring tools, and improving patient self-management in chronic lung disease. The team collaborates widely across Australia and internationally, particularly in trials involving pulmonary rehabilitation and treatable traits.
Danielle Butler is a Visiting Fellow at the National Centre for Epidemiology and Population Health, Australian National University, and a part-time General Practitioner/Researcher at the Institute of Urban Indigenous Health. With 20+ years clinical experience and a PhD (2018), her work focuses on healthcare access equity for underserved populations through linked data analysis, mixed-methods research, and telehealth evaluation. Current projects: Enhancing Safe Telehealth , Patient-Centered Medical Homes , Primary Care Data Linkage Key collaborations: ANU, IUIH, Australian Institute of Health and Welfare Her research combines multilevel modeling of administrative data with participatory action research to evaluate primary care innovations. Recent work examines telehealth impacts , out-of-pocket costs , and Aboriginal health service models . Publications span BMJ Open , BMC Health Services Research , and Health Policy , with emphasis on systematic reviews , linked data methodology , and health equity metrics . Research fingerprint shows dominant themes: Primary Health Care (100%), Aboriginal and Torres Strait Islander Health (66%), Health Services Research (49%), and Telehealth (100%).
Dr. Suman Adhikari is a Conjoint Lecturer at the School of Clinical Medicine , University of New South Wales (UNSW), focusing on Infectious Diseases , Antimicrobial Stewardship , and Clinical Pharmacology . He has contributed to advancements in antibiotic management, sepsis diagnostics, and e-learning tools for healthcare professionals. University: University of New South Wales School: School of Clinical Medicine Email: suman.adhikari@unsw.edu.au Research Interests: Dr. Adhikari’s work spans antimicrobial stewardship in tertiary care, therapeutic drug monitoring of antibiotics like linezolid, and educational technology for vancomycin use. He also explores pharmacokinetics in parasitic infections and contributes to sepsis pathway optimization . Publication Trends: His recent articles (2017–2023) highlight antibiotic safety , digital education , and infection control . Notable studies include multimodal stewardship in ICU, qSOFA criteria validation, and e-learning tool efficacy for vancomycin training. Contact: Phone: 0411817996 | Location: Gray Street, Kogarah 2217 NSW
Professor Chris Greening is a Research Professor in the Department of Microbiology at Monash University, leading the One Health Microbiology group at the Biomedicine Discovery Institute. He holds a first-class degree in Molecular and Cellular Biochemistry from the University of Oxford (2010) and a PhD from the University of Otago (2013). His career includes postdoctoral roles at Otago, CSIRO, and the Australian National University, followed by appointments as a group leader in Monash’s School of Biological Sciences (2016) and a medically-focused NHMRC EL2 Fellow in the Department of Microbiology (2020). Research Focus: Bacterial persistence mechanisms, microbial metabolism, antimicrobial resistance (AMR), and One Health approaches linking environmental, clinical, and public health challenges. Awards: Fenner Medal (2022) and Jim Pittard Award (2019). Key Projects: RISE, Global Research Alliance on Agricultural GHGs, SAEF, and the ARC Carbon Utilisation Hub. Leads Monash’s AMR R&D Facility. Research spans metabolic pathways enabling bacterial survival in extreme conditions (e.g., hydrogen oxidation, F420 cofactor roles), climate impacts (greenhouse gas regulation), and translational programs addressing diarrheal diseases and AMR. Grants: ARC DECRA Fellowship, NHMRC EL2 Fellowship. Cross-disciplinary collaborations with engineers, ecologists, social scientists, and industry. Lab facilities include advanced microbiology, structural biology, and systems biology tools. Contributions align with UN SDGs: climate action (SDG13), good health (SDG3), and sustainable cities (SDG11).
Suzanne Estaphan is a Senior Lecturer in Medical Science (Physiology and Clinical Pharmacology) at the Australian National University (ANU) School of Medicine and Psychology . She holds qualifications including a Doctorate of Physiology (2015) , MSc in Physiology (2012) , MBBCh (2005) , and Basic Certificate in Medical Education (2018) . Her academic roles span curriculum development, admissions, and assessment committees in the ANU Medical School. Senior Lecturer, ANU (2023–present) Academic Editor, PLOS ONE (2024–present) Review Editor, Frontiers in Physiology (2023–present) Dr. Estaphan's research bridges oxidative stress and inflammation in disease pathology with medical education innovation . Her work explores antioxidant interventions for organ damage and investigates AI/virtual reality applications in education. Recent projects include studying sleep dysfunction in eating disorders and diabetes medication effects on exercise capacity . Between 2023–2025, her 15 most recent publications span oxidative stress , medical education , and molecular pathophysiology . Themes include homeostasis , clinical reasoning , and metabolic disorders , with subfields like MMP-9 biology , pancreatic injury , and VR-based hypoxia training . Scientific accolades include the American Physiological Society Travel Award (2017) and recognition as Senior Fellow of the Higher Education Academy (2023) . She mentors medical students, contributes to national physiology curriculum consensus projects, and has secured approximately $200,000 in research funding .
